Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Scientific Concept of the National Cohort (status ... - Nationale Kohorte
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A.3<br />
A.3 Study design<br />
index, conventional methods using oscillometric blood pressure measurement devices and<br />
hand-held Doppler devices to detect systolic blood pressure at <strong>the</strong> brachial artery, <strong>the</strong> dorsal<br />
artery <strong>of</strong> foot, and posterior tibial artery are available as well.<br />
For <strong>the</strong> <strong>National</strong> <strong>Cohort</strong>, one <strong>of</strong> <strong>the</strong> multifunctional devices will be used. The potential <strong>of</strong><br />
<strong>the</strong> Vascular Explorer or <strong>the</strong> Vicorder device to replace <strong>the</strong> more observer-dependent and<br />
time-consuming use <strong>of</strong> <strong>the</strong> Sphygmocor device in <strong>the</strong> <strong>National</strong> <strong>Cohort</strong> will be evaluated in<br />
a feasibility study.<br />
Carotid sonography: intima–media thickness<br />
A<strong>the</strong>rosclerotic disease begins in early life, progresses over decades 581 , and may result<br />
in rupture or erosion <strong>of</strong> existing plaques, leading to MI or stroke 582 . The degree <strong>of</strong> subclinical<br />
a<strong>the</strong>rosclerosis as defined by CIMT or presence <strong>of</strong> carotid plaques is a predictor<br />
<strong>of</strong> incident CVD events in <strong>the</strong> absence <strong>of</strong> overt CVD 583-588 . Vascular imaging such as CIMT<br />
measurements with B-mode ultrasound is a noninvasive, sensitive, and reproducible technique<br />
for identifying and quantifying a<strong>the</strong>rosclerotic burden and CVD risk and can be used<br />
as a screening tool that improves risk prediction beyond application <strong>of</strong> major risk factors<br />
alone 589-591 .<br />
By including carotid ultrasound measures as a surrogate <strong>of</strong> subclinical a<strong>the</strong>rosclerosis in<br />
<strong>the</strong> examination protocol <strong>of</strong> <strong>the</strong> <strong>National</strong> <strong>Cohort</strong> we can compare our results with those <strong>of</strong><br />
o<strong>the</strong>r large-scale epidemiologic studies.<br />
Procedure <strong>of</strong> measurement:<br />
High-resolution B-mode ultrasound systems with linear ultrasound transducers (frequencies<br />
≥ 7 MHz) represent <strong>the</strong> standard equipment for measuring CIMT and plaques. For <strong>the</strong> <strong>National</strong><br />
<strong>Cohort</strong>, a combined ultrasound system will be used for echocardiography and carotid<br />
artery imaging. Examinations will be perfomed by trained and certified investigators and will<br />
be done at both carotid arteries. External landmarks (e.g., <strong>the</strong> Meijer arc or similar devices)<br />
will be used to standardize transducer angle. CIMT is measured preferably on <strong>the</strong> far wall<br />
from multiple sequences <strong>of</strong> longitudinal scans <strong>of</strong> <strong>the</strong> common carotid artery. The reading<br />
will be done <strong>of</strong>fline using automated reading s<strong>of</strong>tware. Carotid plaques will be evaluated at<br />
<strong>the</strong> near and far walls <strong>of</strong> common carotid artery, bulb, and internal carotid artery segments.<br />
Scanning and measurement procedures as well as definitions <strong>of</strong> CIMT and carotid plaques<br />
will be in accordance with current guidelines 592, 593 .<br />
long-term ECG recording and sleep-related characteristics<br />
Atrial fibrillation (including silent, undiagnosed atrial fibrillation) is <strong>the</strong> most common cardiac<br />
arrhythmia. It is associated with a doubling <strong>of</strong> <strong>the</strong> death rate and with substantial increases<br />
in severe cardiovascular complications such as stroke, acute coronary syndrome, and heart<br />
failure.<br />
Many clinically relevant ECG changes such as atrial fibrillation are transient, and <strong>the</strong> search<br />
for such changes can be lengthy and cumbersome, e.g., evaluating syncope or palpitations.<br />
Conventional Holter ECG recordings <strong>of</strong>ten miss transient ECG changes (e.g., intermittent<br />
atrial fibrillation, paroxysmal tachycardias, or intermittent AV block). In <strong>the</strong> <strong>National</strong> <strong>Cohort</strong>,<br />
we aim to record at least a 24-h holter ECG, if possible taking a 7-day recording. Simple,<br />
easy-to-carry-and-apply automatic and/or patient-activated ECG recording systems make it<br />
possible to record an ECG over an extended period <strong>of</strong> time (e.g., 7 days) in epidemiologic<br />
studies.<br />
90